17 May 2021 - The key to developing follow-up of medicines and medical technology products is the national health data registers, as the Swedish Dental and Pharmaceutical Benefits Agency, TLV, does not have access to data for follow-up via the national service platform.
This is the opinion of TLV in a report to the government which, among other things, focuses on how different data sources can be used to develop the authority's opportunities for follow-up.